Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 24;59(6):2830-2836.
doi: 10.1021/acs.jcim.9b00298. Epub 2019 Jun 4.

Understanding Ligand Binding Selectivity in a Prototypical GPCR Family

Affiliations

Understanding Ligand Binding Selectivity in a Prototypical GPCR Family

Giulio Mattedi et al. J Chem Inf Model. .

Abstract

Adenosine receptors are involved in many pathological conditions and are thus promising drug targets. However, developing drugs that target this GPCR subfamily is a challenging task. A number of drug candidates fail due to lack of selectivity which results in unwanted side effects. The extensive structural similarity of adenosine receptors complicates the design of selective ligands. The problem of selective targeting is a general concern in GPCRs, and in this respect adenosine receptors are a prototypical example. Here we use enhanced sampling simulations to decipher the determinants of selectivity of ligands in A2a and A1 adenosine receptors. Our model shows how small differences in the binding pocket and in the water network around the ligand can be leveraged to achieve selectivity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
ZM241385 bound to the binding sites of (a) A2aR and (b) A1R in the enhanced-sampling simulations. (c) The salt bridge hindering the pocket entrance is shown as spheres. A zoomed view of the ligands in the binding sites and the key residues is presented in the boxes.
Figure 2
Figure 2
Ligands in this study, ZM241385 and LUF5452.
Figure 3
Figure 3
Analysis of the conformations adopted by ZM241385 and LUF5452 in the binding pocket of A2aR and A1R over the unbiased MD simulation. Probability over the space defined by the RMSD of the common heavy atoms of the ligands to the conformation adopted in PDB 5IU4 or 3PWH, after alignment to the backbone of the proteins. TM7 not shown for clarity.
Figure 4
Figure 4
Solvation of the 4-hydroxyphenyl or phenyl groups of the ligands over the unbiased MD simulations, represented by the number of water oxygen atoms within 4 Å from the moieties’ heavy atoms. The plots illustrate the average solvation and its standard deviation as a function of the RMSD of the ligand to an upright, 5IU4-like conformation (see Figure 3). Conformations A and B show the displacement of water molecules in the hydrophobic ECV pocket of A1R by LUF5452.
Figure 5
Figure 5
Projection of the free energy landscapes onto Z-projection and XY-projection by reweighting. Boxes: Representative conformations of the ligands bound to the main binding site of the receptors, LUF5452 interacting with the hydrophobic ECV pocket in A1R, and the two molecules breaking the salt bridge at the entrance of the orthosteric site of the proteins.
Figure 6
Figure 6
Representative binding or unbinding paths of the ligands, extracted from the PT-metaD simulations. The ligands need to break the salt bridge at the entrance of the binding site in order to unbind. Extensive interactions with ECL2 are found before complete solvation of the ligands in the fully unbound states.

References

    1. Sheth S.; Brito R.; Mukherjea D.; Rybak L.; Ramkumar V. Adenosine Receptors: Expression, Function and Regulation. Int. J. Mol. Sci. 2014, 15, 2024–2052. 10.3390/ijms15022024. - DOI - PMC - PubMed
    1. Fredholm B. B.; IJzerman A. P.; Jacobson K. A.; Linden J.; Muller C. E. International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update. Pharmacol. Rev. 2011, 63, 1–34. 10.1124/pr.110.003285. - DOI - PMC - PubMed
    1. Jacobson K. A.; Gao Z.-G. Adenosine Receptors as Therapeutic Targets. Nat. Rev. Drug Discovery 2006, 5, 247–264. 10.1038/nrd1983. - DOI - PMC - PubMed
    1. Molero Y.; Gumpert C.; Serlachius E.; Lichtenstein P.; Walum H.; Johansson D.; Anckarsäter H.; Westberg L.; Eriksson E.; Halldner L. A Study of the Possible Association Between Adenosine A2A receptor Gene Polymorphisms and Attention-deficit Hyperactivity Disorder Traits. Genes, Brain Behav. 2013, 12, 305–310. 10.1111/gbb.12015. - DOI - PubMed
    1. Chen J.-F.; Eltzschig H. K.; Fredholm B. B. Adenosine Receptors as Drug Targets - What Are the Challenges?. Nat. Rev. Drug Discovery 2013, 12, 265–286. 10.1038/nrd3955. - DOI - PMC - PubMed

Publication types

MeSH terms